Clinical and economic outcomes of conversion of simvastatin to lovastatin in a group-model health maintenance organization.

Journal of managed care pharmacy : JMCP

Volumn 11, Issue 8, 2005, Pages 681-686

  Billups, Sarah J ^a   Plushner, Susyn L ^a   Olson, Kari L ^a   Koehler, Thomas J ^a   Kerzee, Jane ^a  

^a KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENERIC DRUG; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; SIMVASTATIN;

AGED; ARTICLE; BLOOD; COMPARATIVE STUDY; COST CONTROL; DRUG COST; ECONOMICS; FEMALE; FINANCIAL MANAGEMENT; HEALTH MAINTENANCE ORGANIZATION; HUMAN; MALE; METHODOLOGY; PATIENT; PATIENT COMPLIANCE; RETROSPECTIVE STUDY; STATISTICS; TREATMENT OUTCOME;

AGED; ANTICHOLESTEREMIC AGENTS; CHOLESTEROL, LDL; COST SAVINGS; DRUG COSTS; DRUGS, GENERIC; FEMALE; FINANCING, PERSONAL; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; LOVASTATIN; MALE; PATIENT COMPLIANCE; PATIENTS; RETROSPECTIVE STUDIES; SIMVASTATIN; TREATMENT OUTCOME;

EID: 33746702642     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2005.11.8.681     Document Type: Article

References (0)